Galacto-oligosaccharides may directly enhance intestinal barrier function through the modulation of goblet cells

Molecular Nutrition and Food Research

Volumn 59, Issue 3, 2015, Pages 566-573

  Bhatia, Shikha ^a   Prabhu, P Nagendra ^a   Benefiel, Ann C ^a   Miller, Michael J ^a   Chow, Jomay ^c   Davis, Steven R ^c   Gaskins, H Rex ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

Galacto oligosaccharides; Golgi sulfotransferases; LS174T goblet cells; RELM ; RETNLB

Indexed keywords

LOTUS;

CARBOHYDRATE SULFOTRANSFERASES; GAL3ST2 PROTEIN, HUMAN; INTERLEUKIN 13; INTERLEUKIN 8; MUC2 PROTEIN, HUMAN; MUCIN 2; OLIGOSACCHARIDE; PEPTIDE; RETNLB PROTEIN, HUMAN; SIGNAL PEPTIDE; SULFOTRANSFERASE; SULFURTRANSFERASE; TFF3 PROTEIN, HUMAN;

CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GOBLET CELL; HUMAN; INTESTINE MUCOSA; METABOLISM; SECRETION (PROCESS);

CELL LINE; GENE EXPRESSION REGULATION; GOBLET CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-13; INTERLEUKIN-8; INTESTINAL MUCOSA; MUCIN-2; OLIGOSACCHARIDES; PEPTIDES; SULFOTRANSFERASES; SULFURTRANSFERASES;

EID: 84924015110     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400639     Document Type: Article

References (49)

1. Sako, T., Matsumoto, K., Tanaka, R., Recent progress on research and applications of non-digestible galacto-oligosaccharides. Int. Dairy J. 1999, 9, 69-80.
2. Torres, D. P. M., Gonçalves, M. d. P. F., Teixeira, J. A., Rodrigues, L. R., Galacto-oligosaccharides: Production, properties, applications, and significance as Prebiotics. Compr. Rev. Food Sci. Food Saf. 2010, 9, 438-454.
3. Gibson, G. R., Roberfroid, M. B., Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995, 125, 1401-1412.
4. Roberfroid, M. B., Prebiotics and probiotics: are they functional foods? Am. J. Clin. Nutr. 2000, 71(6 Suppl), 1682S-1687S; discussion 1688S-1690S.
5. MacFarlane, G. T., Steed, H., Macfarlane, S., Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J. Appl. Microbiol. 2008, 104, 305-344.
6. Marques, T. M., Wall, R., Ross, R. P., Fitzgerald, G. F. et al., Programming infant gut microbiota: influence of dietary and environmental factors. Curr. Opin. Biotechnol. 2010, 21, 149-156.
7. Boehm, G., Moro, G., Structural and functional aspects of prebiotics used in infant nutrition. J. Nutr. 2008, 138, 1818S-1828S.
8. Fanaro, S., Boehm, G., Garssen, J., Knol, J. et al., Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review. Acta Paediatr. Suppl. 2005, 94, 22-26.
9. Newburg, D. S., Oligosaccharides in human milk and bacterial colonization. J. Pediatr. Gastroenterol. Nutr. 2000, 30(Suppl 2), S8-17.
10. Searle, L. E., Cooley, W. A., Jones, G., Nunez, A. et al., Purified galactooligosaccharide, derived from a mixture produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium adhesion and invasion in vitro and in vivo. J. Med. Microbiol. 2010, 59(Pt 12), 1428-1439.
11. Shoaf, K., Mulvey, G. L., Armstrong, G. D., Hutkins, R. W., Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Inf. Immun. 2006, 74, 6920-6928.
12. Dharmani, P., Srivastava, V., Kissoon-Singh, V., Chadee, K., Role of intestinal mucins in innate host defense mechanisms against pathogens. J. Innate Immun. 2009, 1, 123-135.
13. Gum, J. R., Byrd, J. C., Hicks, J. W., Toribara, N. W. et al., Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J. Biol. Chem. 1989, 264, 6480-6487.
14. Andrianifahanana, M., Moniaux, N., Batra, S. K., Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim. Biophys. Acta 2006, 1765, 189-222.
15. Davis, C. W., Dickey, B. F., Regulated airway goblet cell mucin secretion. Ann. Rev. Physiol. 2008, 70, 487-512.
16. Kim, Y. S., Ho, S. B., Intestinal goblet cells and mucins in health and disease: recent insights and progress. Curr. Gastroenterol. Rep. 2010, 12, 319-330.
17. Kjellev, S., The trefoil factor family-small peptides with multiple functionalities. Cell Mol. Life Sci. 2009, 66, 1350-1369.
18. Taupin, D., Podolsky, D. K., Trefoil factors: initiators of mucosal healing. Nat. Rev. Mol. Cell. Biol. 2003, 4, 721-732.
19. Kindon, H., Pothoulakis, C., Thim, L., Lynch-Devaney, K. et al., Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 1995, 109, 516-523.
20. Tomasetto, C., Masson, R., Linares, J. L., Wendling, C. et al., pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology 2000, 118, 70-80.
21. Artis, D., Wang, M. L., Keilbaugh, S. A., He, W. et al., RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc. Natl. Acad. Sci. USA 2004, 101, 13596-13600.
22. He, W., Wang, M. L., Jiang, H. Q., Steppan, C. M. et al., Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology 2003, 125, 1388-1397.
23. Deplancke, B., Gaskins, H. R., Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am. J. Clin. Nutr. 2001, 73, 1131S-1141S.
24. Gottke, M. U., Keller, K., Belley, A., Garcia, R. M. et al., Functional heterogeneity of colonic adenocarcinoma mucins for inhibition of Entamoeba histolytica adherence to target cells. J. Eukaryot. Microbiol. 1998, 45, 17S-23S.
25. Brockhausen, I., Pathways of O-glycan biosynthesis in cancer cells. Biochim. Biophys. Acta 1999, 1473, 67-95.
26. Robbe, C., Capon, C., Coddeville, B., Michalski, J. C., Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem. J. 2004, 384(Pt 2), 307-316.
27. Seko, A., Nagata, K., Yonezawa, S., Yamashita, K., Down-regulation of Gal 3-O-sulfotransferase-2 (Gal3ST-2) expression in human colonic non-mucinous adenocarcinoma. Jpn. J. Cancer Res. 2002, 93, 507-515.
28. Lee, J. K., Bistrup, A., van Zante, A., Rosen, S. D., Activities and expression pattern of the carbohydrate sulfotransferase GlcNAc6ST-3 (I-GlcNAc6ST): functional implications. Glycobiology 2003, 13, 245-254.
29. Nishimura, M., Naito, S., Tissue-specific mRNA expression profiles of human carbohydrate sulfotransferase and tyrosylprotein sulfotransferase. Biol. Pharm. Bull. 2007, 30, 821-825.
30. Croix, J. A., Bhatia, S., Gaskins, H. R., Inflammatory cues modulate the expression of secretory product genes, Golgi sulfotransferases and sulfomucin production in LS174T cells. Exp. Biol. Med. (Maywood) 2011, 236, 1402-1412.
31. Almeida, J. A., Ponnuraj, N. P., Lee, J. J., Utterback, P. et al., Effects of dietary clays on performance and intestinal mucus barrier of broiler chicks challenged with Salmonella enterica serovar Typhimurium and on goblet cell function in vitro. Poult. Sci. 2014, 93, 839-847.
32. Kim, Y., Kim, S. H., Whang, K. Y., Kim, Y. J. et al., Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. J. Microbiol. Biotechnol. 2008, 18, 1278-1285.
33. Kunz, C., Rudloff, S., Baier, W., Klein, N. et al., Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Ann. Rev. Nutr. 2000, 20, 699-722.
34. Herbert, D. R., Yang, J. Q., Hogan, S. P., Groschwitz, K. et al., Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J. Exp. Med. 2009, 206, 2947-2957.
35. Krimi, R. B., Kotelevets, L., Dubuquoy, L., Plaisancie, P. et al., Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice. Inflamm. Bowel Dis. 2008, 14, 931-941.
36. Leforestier, G., Blais, A., Blachier, F., Marsset-Baglieri, A. et al., Effects of galacto-oligosaccharide ingestion on the mucosa-associated mucins and sucrase activity in the small intestine of mice. Eur. J. Nutr. 2009, 48, 457-464.
37. Brown, G. D., Taylor, P. R., Reid, D. M., Willment, J. A. et al., Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 2002, 196, 407-412.
38. Drummond, R. A., Brown, G. D., The role of Dectin-1 in the host defence against fungal infections. Curr. Opin. Microbiol. 2011, 14, 392-399.
39. Gross, O., Gewies, A., Finger, K., Schafer, M. et al., Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006, 442, 651-656.
40. Kunsch, C., Rosen, C. A., NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol. Cell. Biol. 1993, 13, 6137-6146.
41. Iwashita, J., Sato, Y., Sugaya, H., Takahashi, N. et al., mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol. Cell. Biol. 2003, 81, 275-282.
42. Eiwegger, T., Stahl, B., Haidl, P., Schmitt, J. et al., Prebiotic oligosaccharides: in vitro evidence for gastrointestinal epithelial transfer and immunomodulatory properties. Pediatr. Allergy Immunol. 2010, 21, 1179-1188.
43. Tanabe, S., Hochi, S., Oral administration of a galactooligosaccharide preparation inhibits development of atopic dermatitis-like skin lesions in NC/Nga mice. Int. J. Mol. Med. 2010, 25, 331-336.
44. Zenhom, M., Hyder, A., de Vrese, M., Heller, K. J. et al., Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPARgamma and peptidoglycan recognition protein 3. J. Nutr. 2011, 141, 971-977.
45. Mazza, J., Rossi, A., Weinberg, J. M., Innovative uses of tumor necrosis factor alpha inhibitors. Dermatol. Clin. 2010, 28, 559-575.
46. Lugering, N., Kucharzik, T., Kraft, M., Winde, G. et al., Interleukin (IL)-13 and IL-4 are potent inhibitors of IL-8 secretion by human intestinal epithelial cells. Dig. Dis. Sci. 1999, 44, 649-655.
47. Gourbeyre, P., Desbuards, N., Gremy, G., Le Gall, S. et al., Exposure to a galactooligosaccharides/inulin prebiotic mix at different developmental time points differentially modulates immune responses in mice. J. Agric. Food Chem. 2012, 60, 11942-11951.
48. Ortega-González, M., Ocón, B., Romero-Calvo, I., Anzola, A. et al., Nondigestible oligosaccharides exert nonprebiotic effects on intestinal epithelial cells enhancing the immune response via activation of TLR4-NFkappaB. Mol. Nutr. Food Res. 2014, 58, 384-393.
49. Sangwan, V., Tomar, S. K., Singh, R. R., Singh, A. K. et al., Galactooligosaccharides: novel components of designer foods. J. Food Sci. 2011, 76, R103-111.